DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

DoubleTree Bethesdan

2019年9月19日 (木) 午前 7:00 - 2019年9月20日 (金) 午後 3:15

8120 Wisconsin Avenue, , Bethesda, MD 20814 , USA

Global Clinical Trial Disclosure and Data Transparency Conference

Learn about the latest global requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.

Session 3: Good Compliance is Good Business

Session Chair(s)

Francine  Lane, MBA

Francine Lane, MBA

Senior Director of Product Management

Citeline, United States

The public continues to pay close attention to clinical trial disclosures. Large pharma is no longer the primary focus of analyses by transparency advocates but studies from organizations from all sizes and shapes are highlighted when study results are not shared in a timely manner. In this session, we’ll hear from funders and transparency advocates to understand why disclosure is important, what is ‘good’ compliance, and some best practices to help your organization become better with clinical trial disclosures and compliance.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify major stakeholders for clinical trial disclosure information
  • Assess why good compliance is important to different stakeholder groups
  • Discuss best practices to achieve good compliance

Speaker(s)

Georgina  Humphreys, PhD, MSc

Why Transparency is Important to Us (Remote Presentation)

Georgina Humphreys, PhD, MSc

Wellcome Trust, United Kingdom

Clinical Data Sharing Manager

Thomas  Wicks, MBA

Trends and Best Practices in Trial Disclosure

Thomas Wicks, MBA

Citeline, United States

Head of Transparency Operations

Till  Bruckner, PhD

Evolving Transparency Expectations: The Road Ahead (Remote Presentation)

Till Bruckner, PhD

TranspariMED, United Kingdom

Founder

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。